# US 2021/0330913 A1 · Methods and apparatus for controlling respiratory therapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330913 A1
- Document ID: US20210330913A1
- Status: Published application
- Kind: A1
- Application number: 17/270,209
- Filed: 2019-08-20
- Published: 2021-10-28
- Earliest claimed: 2018-08-23
- Assignees: ResMed Pty Ltd
- Applicants: ResMed Pty Ltd
- Inventors: Dion Charles Chewe MARTIN
- Web page: https://patentgrep.com/patent/US20210330913A1

## CPC

- A61M 16/022: {Control means therefor}
- A61M 16/024: {including calculation means, e.g. using a processor}
- A61M 16/0003: {Accessories therefor, e.g. sensors, vibrators, negative pressure}
- A61M 16/0063: {Compressors}
- A61M 16/0069: {the speed thereof being controlled by respiratory parameters, e.g. by inhalation}
- A61M 16/0672: {Nasal cannula assemblies for oxygen therapy}
- A61M 16/101: {using an oxygen concentrator}
- A61M 16/1055: {bacterial}
- A61M 16/107: {in the inspiratory path}
- A61M 16/109: {the humidifying liquid or the beneficial agent}
- G16H 20/40: relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
- G16H 40/63: for local operation
- A61M 16/0051: {with alarm devices}
- A61M 16/0072: {Tidal volume piston pumps}
- A61M 16/0075: {Bellows-type}
- A61M 16/06: Respiratory or anaesthetic masks
- A61M 16/0875: {Connecting tubes}
- A61M 16/203: {Proportional}
- A61M 16/208: {Non-controlled one-way valves, e.g. exhalation, check, pop-off non-rebreathing valves}
- A61M 2016/0021: {with a proportional output signal, e.g. from a thermistor}
- A61M 2016/0027: {pressure meter}
- A61M 2016/0039: {in the inspiratory circuit}
- A61M 2016/1025: {the O2 concentration}
- A61M 2039/2406: {designed to quickly shut upon the presence of back-pressure}
- A61M 2202/0208: Oxygen
- A61M 2202/0266: Nitrogen (N)
- A61M 2205/18: with alarm
- A61M 2205/3306: Optical measuring means
- A61M 2205/3317: Electromagnetic, inductive or dielectric measuring means
- A61M 2205/3334: Measuring or controlling the flow rate
- A61M 2205/3368: Temperature
- A61M 2205/3375: Acoustical, e.g. ultrasonic, measuring means
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/3561: local, e.g. within room or hospital
- A61M 2205/3569: sublocal, e.g. between console and disposable
- A61M 2205/3584: using modem, internet or Bluetooth®
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/42: Reducing noise
- A61M 2205/505: Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
- A61M 2205/581: by audible feedback
- A61M 2205/582: by tactile feedback
- A61M 2205/583: by visual feedback
- A61M 2205/7518: bacterial
- A61M 2205/7545: for solid matter, e.g. microaggregates
- A61M 2205/82: Internal energy supply devices
- A61M 2209/01: Remote controllers for specific apparatus
- A61M 2209/086: Docking stations
- A61M 2210/1039: Lungs
- A61M 2230/202: partial carbon oxide pressure, e.g. partial dioxide pressure (P-CO2)
- A61M 2230/40: Respiratory characteristics
- A61M 2230/42: Rate
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Methods and apparatus involve generation of an anti-infection therapy. The method/apparatus may include a controller controlling setting of a respiratory flow therapy device for the therapy. The controller may compute a target flow rate profile for a patient using a margin function, such that the target flow rate profile, according to the margin function, exceeds a minimum inspiratory flow rate profile of the patient's inspiration. The controller may control setting the respiratory flow therapy device to generate a flow of air to a patient interface according to the target flow rate profile, where the generation may be in synchrony with a sensed parameter that is indicative of a breathing cycle of the patient.

## Claims

### Claim 1

A method of a controller controlling setting of a respiratory flow therapy device for an anti-infection therapy, the method comprising:
computing, by the controller of the respiratory flow therapy device, a target flow rate profile for a patient using a margin function, such that the target flow rate profile exceeds, according to the margin function, a minimum inspiratory flow rate profile of the patient's inspiration; and
controlling setting of the respiratory flow therapy device to generate a flow of air with the respiratory flow therapy device according to the target flow rate profile, wherein the generation is in synchrony with a sensed parameter that is indicative of a breathing cycle of the patient.

### Claim 2 (depends on 1)

The method of claim 1 wherein the margin function is configured such that the target flow rate profile marginally exceeds the minimum inspiratory flow rate profile of the patient.

### Claim 3 (depends on 1, 2)

The method of any one of claims 1 to 2, wherein the computing comprises:
computing the minimum inspiratory flow rate profile of the patient.

### Claim 4 (depends on 1, 2, 3)

The method of any one of claims 1 to 3 wherein computing the target flow rate profile during inspiration comprises adding the margin function to the minimum inspiratory flow rate profile.

### Claim 5 (depends on 4)

The method of claim 4 wherein the margin function is a function of a peak inspiratory flow rate.

### Claim 6 (depends on 5)

The method of claim 5, further comprising estimating the peak inspiratory flow rate.

### Claim 7 (depends on 5, 6)

The method of any one of claims 5 to 6 wherein the function of the peak inspiratory flow rate comprises a percentage.

### Claim 8 (depends on 7)

The method of claim 7 wherein the percentage is in a range of 10 to 30 percent.

### Claim 9 (depends on 4)

The method of claim 4 wherein the margin function comprises a multiple of the minimum inspiratory flow rate profile.

### Claim 10 (depends on 9)

The method of claim 9 wherein the multiple is in a range of 0.1 to 0.3.

### Claim 11 (depends on 3)

The method of claim 3 wherein computing the minimum inspiratory flow rate profile comprises:
estimating a peak inspiratory flow rate of the patient based on the patient's height, and
computing the minimum inspiratory flow rate profile from the peak inspiratory flow rate.

### Claim 12 (depends on 11)

The method of claim 11 wherein estimating the peak inspiratory flow rate comprises computing an estimate of anatomic deadspace, computing an estimate of minimum ventilation, and computing an estimate of minimum tidal volume.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method of any of claims 1 to 12, wherein computing the target flow rate profile during expiration comprises setting the target flow rate profile to zero.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any of claims 1 to 13, further comprising:
computing a new target flow rate profile for the patient, and
controlling setting of the respiratory flow therapy device to further generate a flow of air with the respiratory flow therapy device according to the new target flow rate profile, wherein the further generation is in synchrony with a sensed parameter that is indicative of a subsequent breathing cycle of the patient.

### Claim 15 (depends on 14)

The method of claim 14, wherein computing the new target flow rate profile comprises:
estimating at least one value of nasal pressure of the patient over an inspiratory portion of a breathing cycle of the patient, and
computing a new target flow rate profile based on the at least one nasal pressure value.

### Claim 16 (depends on 15)

The method of claim 15 wherein estimating at least one value of nasal pressure of the patient over an inspiratory portion of the patient's breathing cycle comprises:
receiving a measure of pressure and adjusting the measure of pressure according to a characteristic function of an air circuit of the respiratory flow therapy device through which the pressure is measured.

### Claim 17 (depends on 16)

The method of claim 16 wherein the characteristic function comprises a measured flow value and a pressure drop value.

### Claim 18 (depends on 15, 16, 17)

The method of any one of claims 15 to 17, wherein computing the new target flow rate profile comprises:
controlling adjustment to a peak inspiratory flow rate based on the at least one nasal pressure value,
computing a new minimum inspiratory flow rate profile of the patient from the adjusted peak inspiratory flow rate, and
computing the new target flow rate profile using the margin function.

### Claim 19 (depends on 18)

The method of claim 18 wherein controlling adjustment to the peak inspiratory flow rate comprises (a) decreasing the peak inspiratory flow rate if the at least one nasal pressure value is above a threshold target; and/or (b) increasing the peak inspiratory flow rate if the at least one nasal pressure value is below a threshold target.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

The method of any one of claims 1 to 19 wherein computing the target flow rate profile comprises receiving estimated breath timing parameters.

### Claim 21 (depends on 20)

The method of claim 20 wherein the estimated breath timing parameters comprise an estimated breathing rate and/or an estimated inspiratory time.

### Claim 22 (depends on 20, 21)

The method of any one of claims 20 to 21 further comprising computing the estimated breath timing parameters by computing impedance or conductance from pressure and flow signals.

### Claim 23 (depends on 22)

The method of claim 22 further comprising generating a dynamic impedance signal or dynamic conductance signal with the computed impedance or conductance respectively.

### Claim 24 (depends on 23)

The method of claim 23 further comprising determining trigger and/or cycling points from the dynamic impedance signal or the dynamic conductance signal.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any of claims 1 to 24, further comprising controlling an oxygen source to add supplementary oxygen to the generated flow of air.

### Claim 26 (depends on 25)

The method of claim 25, wherein the supplementary oxygen is added in pulsed oxygen delivery (POD) mode.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any one of claims 1 to 26, further comprising conditioning, by a humidifier of the respiratory flow therapy device, the generated flow of air.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

A processor-readable medium, having stored thereon processor-executable instructions which, when executed by a processor of a controller, cause the controller to control setting of a respiratory flow therapy device for an anti-infection therapy according to the method of any one of claims 1 to 27.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

An anti-infection therapy device comprising:
a pressure generator configured to generate a flow of air at a controllable flow rate to a patient interface; and
a controller comprising one or more processors and a memory, the one or more processors configured to execute program instructions stored in the memory, the program instructions configured to perform the method of any one of claims 1 to 28.

### Claim 30

An anti-infection therapy device comprising:
a pressure generator configured to generate a flow of air at a controllable flow rate to a patient interface; and
a controller configured to:
compute a target flow rate profile for a patient using a margin function, such that the target flow rate profile exceeds, according to the margin function, a minimum inspiratory flow rate profile of the patient's inspiration; and
control setting of the pressure generator to generate a flow of air to the patient interface according to the target flow rate profile, wherein the generation is in synchrony with a sensed parameter that is indicative of a breathing cycle of the patient.

### Claim 31 (depends on 30)

The anti-infection therapy device of claim 30, further comprising an oxygen source configured to add supplementary oxygen to the generated flow of air.

### Claim 32 (depends on 31)

The anti-infection therapy device of claim 31, wherein the oxygen source is configured to add the supplementary oxygen in pulsed oxygen delivery (POD) mode.

### Claim 33 (depends on 30, 31, 32)

The anti-infection therapy device of any of claims 30 to 32, further comprising a humidifier configured to condition the generated flow of air.

### Claim 34

Anti-infection therapy apparatus comprising:
means for generating a flow of air at a controllable flow rate to a patient interface;
means for computing a target flow rate profile for a patient using a margin function, such that the target flow rate profile exceeds, according to the margin function, a minimum inspiratory flow rate profile of the patient's inspiration; and
means for controlling the means for generating to generate the flow of air according to the target flow rate profile, wherein the generation is in synchrony with a sensed parameter that is indicative of a breathing cycle of the patient.
